OKYO ▲ +2.0% - OKYO Pharma Limited $OKYO - OKYO Pharma Announces First Patients Enrolled in Phase 3 Pivotal Trial of Urcosimod for Neuropathic Corneal Pain 06-OCT-2026 07:00 AM ET